‘Long-term benefits’ with nivolumab in cHLMay 9, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
CAR T-cell therapy bridges to HSCT in AML patientMay 9, 2018Leukemia, Myelodysplasia, TransplantationTransplantationAML
Cost of imatinib still high despite generic options, team saysMay 8, 2018Leukemia, Myelodysplasia, TransplantationPharmacyCML
Drug granted fast track designations for FL, DLBCLMay 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA issues CRL for proposed biosimilar rituximabMay 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
